Weeratna RD - Search Results

1

Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution.

McCluskie MJ, Weeratna RD, Davis HL. McCluskie MJ, et al. Among authors: weeratna rd. Mol Med. 2000 Oct;6(10):867-77. Mol Med. 2000. PMID: 11126201 Free PMC article.

2

CPG ODN allows lower dose of antigen against hepatitis B surface antigen in BALB/c mice.

Weeratna R, Comanita L, Davis HL. Weeratna R, et al. Immunol Cell Biol. 2003 Feb;81(1):59-62. doi: 10.1046/j.1440-1711.2003.01135.x. Immunol Cell Biol. 2003. PMID: 12534947

3

Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA.

McCluskie MJ, Weeratna RD, Payette PJ, Davis HL. McCluskie MJ, et al. Among authors: weeratna rd. FEMS Immunol Med Microbiol. 2002 Feb 18;32(3):179-85. doi: 10.1111/j.1574-695X.2002.tb00551.x. FEMS Immunol Med Microbiol. 2002. PMID: 11934561 Free article.

4

TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848).

Weeratna RD, Makinen SR, McCluskie MJ, Davis HL. Weeratna RD, et al. Vaccine. 2005 Nov 1;23(45):5263-70. doi: 10.1016/j.vaccine.2005.06.024. Epub 2005 Jul 18. Vaccine. 2005. PMID: 16081189

5

Treatment of intravaginal HSV-2 infection in mice: a comparison of CpG oligodeoxynucleotides and resiquimod (R-848).

McCluskie MJ, Cartier JL, Patrick AJ, Sajic D, Weeratna RD, Rosenthal KL, Davis HL. McCluskie MJ, et al. Among authors: weeratna rd. Antiviral Res. 2006 Feb;69(2):77-85. doi: 10.1016/j.antiviral.2005.10.007. Epub 2005 Dec 5. Antiviral Res. 2006. PMID: 16377001

6

Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge.

Payette PJ, Ma X, Weeratna RD, McCluskie MJ, Shapiro M, Engle RE, Davis HL, Purcell RH. Payette PJ, et al. Among authors: weeratna rd. Intervirology. 2006;49(3):144-51. doi: 10.1159/000089375. Intervirology. 2006. PMID: 16428890

7

CpG ODN and ISCOMATRIX adjuvant: a synergistic adjuvant combination inducing strong T-Cell IFN-γ responses.

McCluskie MJ, Weeratna RD, Evans DM, Makinen S, Drane D, Davis HL. McCluskie MJ, et al. Among authors: weeratna rd. Biomed Res Int. 2013;2013:636847. doi: 10.1155/2013/636847. Epub 2013 Mar 23. Biomed Res Int. 2013. PMID: 23586050 Free PMC article.

8

CpG DNA induces stronger immune responses with less toxicity than other adjuvants.

Weeratna RD, McCluskie MJ, Xu Y, Davis HL. Weeratna RD, et al. Vaccine. 2000 Mar 6;18(17):1755-62. doi: 10.1016/s0264-410x(99)00526-5. Vaccine. 2000. PMID: 10699323

9

The role of CpG in DNA vaccines.

McCluskie MJ, Weeratna RD, Davis HL. McCluskie MJ, et al. Among authors: weeratna rd. Springer Semin Immunopathol. 2000;22(1-2):125-32. doi: 10.1007/s002810000014. Springer Semin Immunopathol. 2000. PMID: 10944807 Review.

10

CpG DNA is an effective oral adjuvant to protein antigens in mice.

McCluskie MJ, Weeratna RD, Krieg AM, Davis HL. McCluskie MJ, et al. Among authors: weeratna rd. Vaccine. 2000 Nov 22;19(7-8):950-7. doi: 10.1016/s0264-410x(00)00215-2. Vaccine. 2000. PMID: 11115721

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters